As per MRFR analysis, the India Genetic Testing Market Size was estimated at 448.0 (USD Million) in 2023.The India Genetic Testing Market Industry is expected to grow from 532.0(USD Million) in 2024 to 2,128.0 (USD Million) by 2035. The India Genetic Testing Market CAGR (growth rate) is expected to be around 13.431% during the forecast period (2025 - 2035)
Key India Genetic Testing Market Trends Highlighted
The India Genetic Testing Market is witnessing significant growth driven by various key market drivers. A rise in awareness about genetic disorders and the benefits of early detection is encouraging more individuals to seek genetic testing services. Additionally, the Indian government is promoting personalized medicine through initiatives and policies aimed at improving healthcare infrastructure. Awareness campaigns about lifestyle-related genetic risks are further contributing to the increased utilization of genetic tests. Opportunities to be explored in this market include the expansion of genetic testing services in rural areas and tier-2 cities, where healthcare access has been limited.Collaborations between public health systems and private companies can help in extending genetic testing services, tailored to local populations' needs.
Moreover, advancements in technology, such as the reduction in costs of genome sequencing, present prospects for wider adoption of these tests among the general public. Recent trends indicate that there is a growing interest in preventive healthcare and wellness among Indians, leading to a higher demand for genetic tests aimed at preventing hereditary diseases. The trend is reinforced by the increasing integration of artificial intelligence in genetic testing services, which enhances the accuracy and efficiency of tests.Parents are increasingly opting for prenatal genetic screening options to understand potential genetic disorders in their unborn children, showcasing a shift towards proactive healthcare. Overall, the India Genetic Testing Market is evolving with these trends, reflecting a positive approach towards health management and inherent genetic risks.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
India Genetic Testing Market Drivers
Increasing Prevalence of Genetic Disorders
The rising incidence of genetic disorders in India is a significant driver for the India Genetic Testing Market Industry. Reports suggest that approximately 1 in 20 individuals in India is expected to be affected by a genetic disorder, with certain conditions, such as thalassemia and sickle cell disease, showing increasing prevalence. The Indian government, through initiatives led by bodies like the Ministry of Health and Family Welfare, is also focusing on early diagnosis and intervention for genetic conditions.This focus underscores the necessity for genetic testing to facilitate timely treatment and management of these disorders, which contributes to the market's growth potential. Furthermore, research indicates a 15% increase in the number of diagnosed genetic disorders, further establishing a pressing need for genetic testing solutions. The presence of established organizations like Apollo Hospitals and Fortis Healthcare, which are investing in advanced genetic testing technologies, enhances this growing market demand.
Growing Awareness and Acceptance of Genetic Testing
There is a notable increase in awareness regarding the benefits of genetic testing among the Indian population. Increased health campaigns and educational programs by organizations such as the Indian Council of Medical Research (ICMR) play a fundamental role in dispelling myths and enhancing understanding of genetic testing. An upward trend shows that in the last five years, nearly 30% more people are opting for genetic counseling and testing, driven by improved accessibility to information.This rising acceptance directly impacts the growth dynamics of the India Genetic Testing Market Industry, making it easier for individuals to make informed health decisions. Educational institutions and medical organizations are actively promoting genetic testing, uncovering its role in personalized healthcare, thereby encouraging a shift in societal perspectives towards these advanced diagnostics.
Technological Advancements in Genetic Testing
Technological innovation in genetic testing methodologies is propelling the growth of the India Genetic Testing Market Industry. The advent of Next-Generation Sequencing (NGS) technology has dramatically decreased testing costs and turnaround times, making genetic testing more accessible to the average Indian. According to recent studies, the adoption rate of NGS in India has surged by over 50% in the past three years, indicating a shift towards more sophisticated and efficient testing methods.Organizations such as BGI Genomics and MedGenome are at the forefront of adopting these technologies, enhancing the precision and reliability of genetic tests. This rise in technological uptake aligns with the Indian government's push for modernization in healthcare infrastructure, ensuring that advanced genetic testing remains a cornerstone of preventive healthcare strategies.
Legislative and Policy Support for Genetic Testing
The Indian government is actively promoting genetic testing through favorable policies and legislative frameworks. The National Health Policy of 2017 emphasizes the need for genetic research and personalized medicine, providing a conducive environment for the growth of the India Genetic Testing Market Industry. With the government's emphasis on healthcare access and affordable treatment, there has been a significant increase in funding and support for genetic testing initiatives.Data shows that funding for healthcare research, including genetic testing, has increased by over 20% during the last budget cycle. The proactive stance of Indian regulatory bodies, including the Central Drugs Standard Control Organization (CDSCO), ensures that genetic testing services meet strict safety and efficacy standards, further fostering public trust and encouraging demand for genetic testing in India.
India Genetic Testing Market Segment Insights
Genetic Testing Market Type Insights
The India Genetic Testing Market has seen substantial growth, driven by the increasing awareness of personalized medicine and preventive healthcare. The Type segment, which encompasses Molecular Genetic Tests/DNA Tests, Chromosomal Genetic Tests, Biochemical Genetic Tests, and others, plays a crucial role in the landscape of genetic testing in the country. Molecular Genetic Tests, commonly referred to as DNA tests, are significant due to their ability to identify genetic disorders at an early stage, which helps in prompt diagnosis and management of diseases. This segment is essential for its application in various fields, including oncology and prenatal testing, thus contributing positively to patient outcomes and overall healthcare costs.
Chromosomal Genetic Tests involve analyzing chromosomes to detect anomalies that might lead to genetic diseases or developmental delays. This testing type is instrumental in reproductive health, particularly for couples with a history of genetic disorders or those undergoing assisted reproductive technologies. Biochemical Genetic Tests assess a person’s metabolic function and are integral for detecting inborn errors of metabolism, allowing for early intervention that can save lives. The "Others" category encompasses a range of tests that don't fall strictly into the previous categories, offering tailored solutions for specific genetic conditions.
These segments not only showcase advancements in genetic testing technology but also reflect the growing acceptance of these tests among healthcare providers and patients within India. The government has been actively promoting genetic testing as a pathway to improve health outcomes nationwide, contributing to an increase in the overall acceptance and utilization of these technologies. The India Genetic Testing Market is set to thrive as advances in genomic research continue to grow, providing ample opportunities for better healthcare solutions while addressing the diverse genetic health needs of the population. Furthermore, the market dynamics are also influenced by regulatory developments, consumer awareness, and the expansion of healthcare infrastructure, all of which impact the Type segment's contributions to the overall market.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Genetic Testing Market Type Insights
The India Genetic Testing Market is experiencing notable segmentation into various types, primarily focusing on Prescribed Genetic Testing and Direct-to-Consumer Genetic Testing. Prescribed Genetic Testing plays a crucial role as it is often utilized in clinical settings, aiding healthcare professionals in diagnosing genetic disorders and tailoring personalized treatment plans to patients. This segment reflects the increasing awareness and acceptance of genetic disorders in India, fostering a proactive approach to healthcare. On the other hand, Direct-to-Consumer Genetic Testing has gained significant traction, driven by growing consumer interest in genetic information for personalized insights regarding health, ancestry, and traits.This segment empowers individuals to take charge of their health decisions but also raises questions surrounding privacy and data security.
The overall India Genetic Testing Market revenue is poised for growth, supported by advancements in technology, wider accessibility of testing services, and an increasing demand for preventive healthcare solutions. With the rise of both segments, the market is likely to provide valuable opportunities and insights for stakeholders, marking a transformational phase in India's healthcare landscape.
Genetic Testing Market Application Insights
The Application segment of the India Genetic Testing Market encompasses a diverse array of uses that significantly impact healthcare delivery in the region. Among these, Reproductive Health plays a crucial role in enabling prospective parents to make informed decisions concerning genetic disorders, thereby enhancing family planning initiatives. Cancer Screening stands out for its importance in early detection, offering a proactive approach to managing cancer risks for the population. Ancestry testing attracts considerable interest, as it assists individuals in tracing their lineage and understanding their genetic heritage, reflecting societal trends toward personal identity and cultural connections.Predictive and Pre-Symptomatic Testing also holds substantial relevance, as it empowers individuals to assess their risk for inherited conditions, facilitating preventive health measures.
The 'Others' category captures emerging applications, showcasing the evolving landscape of the genetic testing field in India is greatly influenced by technological advancements, rising healthcare awareness, and a growing emphasis on personalized medicine. Overall, the integration of genetic testing in these applications aligns with the Indian government's focus on enhancing healthcare services and improving health outcomes, reflecting a shift towards innovative healthcare solutions.
India Genetic Testing Market Key Players and Competitive Insights
The competitive landscape of the India Genetic Testing Market has been evolving significantly, driven by advancements in technology, increased awareness about genetic testing, and a growing demand for personalized medicine. The market comprises various players, ranging from established healthcare giants to new entrants focusing on innovative diagnostic solutions. Companies in this sector are continually investing in research and development, strategic partnerships, and acquisitions to enhance their service offerings and improve accuracy in testing. As the awareness of genetic disorders and hereditary diseases rises among the Indian population, the market is expected to witness an increase in demand for comprehensive genetic testing solutions.
The competitive dynamics are characterized by a wide variety of testing services, including prenatal screening, carrier testing, pharmacogenomics, and oncology testing, which cater to both healthcare providers and consumers. This competition fosters innovation, leading to more accessible and efficient testing facilities tailored diverse patient needs.LabCorp is a prominent player within the Indian Genetic Testing Market, known for its comprehensive suite of lab testing services. The company focuses on providing high-quality genetic testing solutions, greatly enhancing its presence in the region through a network of state-of-the-art laboratories and strategic alliances with healthcare institutions. LabCorp's strengths lie in its commitment to technological advancement and the implementation of data analytics in genetic testing processes.
Their internationally recognized methodologies ensure reliable results for patients and healthcare providers alike, fostering trust and accuracy in testing. With a robust infrastructure and highly trained workforce, LabCorp is well-positioned to address the specific genetic testing needs of the Indian population, making it a significant competitor in this growing market.Aarav Unmanned Systems is another notable entity in the Indian Genetic Testing Market, focusing on deploying advanced technologies to innovate healthcare solutions. Although primarily recognized for its expertise in unmanned systems technology, the company has ventured into genetic testing by developing applications that aid in diagnostic procedures. Aarav Unmanned Systems offers key products aimed at streamlining genetic testing processes, ensuring that testing is not only efficient but also accurate.
This diversification reflects the company's strategic approach to expand its market presence through the integration of technology in healthcare. With its strengths in automation and data collection, Aarav Unmanned Systems positions itself uniquely in the market. The company is also actively exploring mergers and acquisitions to enhance its capabilities and expand its offerings in genetic testing, thus benefiting the dynamic landscape of genetic diagnostics in India while catering to the increasing demand for innovative testing solutions.
Key Companies in the India Genetic Testing Market Include
India Genetic Testing Market Industry Developments
The India Genetic Testing Market has witnessed notable advancements, particularly with the increasing integration of advanced technologies in diagnostic tools. Companies like LabCorp and Thermo Fisher Scientific are enhancing their capabilities to meet the rise in consumer demand for genetic tests driven by the growing prevalence of genetic disorders. In August 2023, MedGenome raised significant funding to expand its genetic testing services, which is expected to bolster their market presence.
Furthermore, in June 2023, Roche announced a collaboration with Narayana Health to offer advanced genetic testing solutions in India, enhancing accessibility for patients. The market has also seen substantial growth in valuation as the Indian government focuses on improving healthcare infrastructure and personalized medicine initiatives. In 2021, Mylab Discovery Solutions launched a new range of genetic tests, aligning with the increasing emphasis on preventive healthcare. Companies like Mapmygenome and Qiagen are also stepping up their product offerings, capitalizing on India's expanding healthcare market. As of October 2023, the sector continues to flourish, reflecting an overall optimistic outlook driven by innovation and strategic partnerships among key players in this dynamic environment.
India Genetic Testing Market Segmentation Insights
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2023 | 448.0(USD Million) |
| MARKET SIZE 2024 | 532.0(USD Million) |
| MARKET SIZE 2035 | 2128.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 13.431% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | LabCorp, Aarav Unmanned Systems, Exact Sciences, Narayana Health, Sakra Premium Diagnostics, Qiagen, Roche, MedGenome, Genomic Health, Thermo Fisher Scientific, Mylab Discovery Solutions, Stelis Biopharma, Illumina, Mapmygenome, Portea Medical |
| SEGMENTS COVERED | Type, Type, Application |
| KEY MARKET OPPORTUNITIES | Growing demand for personalized medicine, Increasing prevalence of genetic disorders, Rising interest in preventive healthcare, Expanding healthcare infrastructure, Advancements in sequencing technologies |
| KEY MARKET DYNAMICS | Increasing prevalence of genetic disorders, Rising awareness of personalized medicine, Government initiatives for healthcare improvements, Advancements in genomic technologies, Growing demand for preventive healthcare |
| COUNTRIES COVERED | India |
Frequently Asked Questions (FAQ) :
The India Genetic Testing Market is expected to be valued at 532.0 USD Million in 2024.
By 2035, the India Genetic Testing Market is projected to reach a value of 2128.0 USD Million.
The expected CAGR for the India Genetic Testing Market from 2025 to 2035 is 13.431%.
In 2035, the Molecular Genetic Tests/ DNA Tests segment will hold the highest market value at 1066.0 USD Million.
The market size for Chromosomal Genetic Tests in 2024 is valued at 132.0 USD Million.
Major players in the India Genetic Testing Market include LabCorp, Exact Sciences, Roche, and MedGenome.
By 2035, the Biochemical Genetic Tests market value is expected to reach 312.0 USD Million.
The growth of the India Genetic Testing Market is driven by rising awareness and advancements in genetic technologies.
The 'Others' category in Genetic Testing is valued at 55.0 USD Million in 2024.
Challenges in the India Genetic Testing Market may include regulatory hurdles and the need for technological advancements.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
